科研製薬
4521
東証プライム
医薬品
科研製薬の決算推移
損益計算書
（単位：百万円）
2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | |
|---|---|---|---|---|---|---|---|---|---|---|
売上高 | 93,889 | 109,730 | 101,479 | 98,430 | 94,165 | 89,232 | 74,979 | 76,034 | 72,984 | 72,044 |
売上原価 | 44,760 | 47,580 | 44,539 | 42,405 | 40,366 | 38,753 | 34,073 | 34,458 | 33,428 | 33,505 |
売上総利益 | 49,129 | 62,149 | 56,940 | 56,024 | 53,799 | 50,478 | 40,906 | 41,575 | 39,555 | 38,539 |
販管費 | 28,504 | 26,490 | 26,745 | 28,530 | 29,209 | 23,969 | 23,118 | 24,511 | 31,556 | 29,025 |
営業利益 | 20,631 | 35,146 | 30,707 | 27,496 | 24,592 | 26,512 | 17,788 | 17,064 | 7,998 | 9,513 |
営業外収益 | 362 | 289 | 343 | 412 | 464 | 549 | 484 | 543 | 780 | 543 |
営業外費用 | 599 | 70 | 69 | 53 | 84 | 114 | 50 | 66 | 51 | 106 |
経常利益 | 20,394 | 35,365 | 30,981 | 27,854 | 24,972 | 26,946 | 18,222 | 17,542 | 8,727 | 9,951 |
特別利益 | 7 | N/A | 252 | N/A | 0 | 7 | 495 | 197 | 4 | 14 |
特別損失 | 1,790 | 73 | 142 | 168 | 49 | 362 | 59 | 3,854 | 1,914 | 168 |
当期純利益 | 12,122 | 21,143 | 22,017 | 19,043 | 17,775 | 19,370 | 13,405 | 9,549 | 5,440 | 8,025 |
貸借対照表
（単位：百万円）
2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | |
|---|---|---|---|---|---|---|---|---|---|---|
資産 | 115,135 | 132,991 | 135,060 | 152,417 | 155,985 | 157,875 | 163,332 | 165,181 | 166,328 | 171,623 |
流動資産 | 69,016 | 88,991 | 90,494 | 105,055 | 103,731 | 108,336 | 113,662 | 110,613 | 109,903 | 106,974 |
現金及び預金 | 10,553 | 29,845 | 33,867 | 45,095 | 46,956 | 59,722 | 63,706 | 61,025 | 59,561 | 50,625 |
売上債権 | 28,204 | 29,868 | 28,231 | 33,315 | 30,340 | 21,800 | 20,549 | 19,982 | 18,889 | 23,326 |
棚卸資産 | 13,482 | 14,506 | 16,495 | 16,651 | 13,719 | 12,274 | 15,197 | 14,980 | 15,563 | 17,167 |
固定資産 | 46,118 | 43,999 | 44,565 | 47,362 | 52,254 | 49,538 | 49,669 | 54,567 | 56,425 | 64,648 |
負債 | 38,035 | 43,116 | 32,405 | 38,543 | 34,854 | 29,406 | 27,074 | 26,855 | 29,491 | 27,868 |
流動負債 | 30,369 | 33,861 | 24,020 | 31,401 | 27,580 | 21,655 | 21,276 | 19,049 | 20,838 | 19,024 |
仕入債務 | 12,295 | 12,256 | 9,854 | 12,204 | 10,729 | 7,720 | 8,425 | 5,861 | 6,130 | 6,976 |
固定負債 | 7,665 | 9,255 | 8,384 | 7,141 | 7,274 | 7,750 | 5,798 | 7,806 | 8,653 | 8,843 |
純資産 | 77,100 | 89,875 | 102,655 | 113,874 | 121,131 | 128,468 | 136,257 | 138,325 | 136,836 | 143,755 |
利益剰余金 | 52,932 | 68,609 | 84,331 | 97,284 | 109,057 | 114,869 | 122,462 | 126,347 | 126,135 | 128,506 |
自己株式 | -16,098 | -16,301 | -19,813 | -23,259 | -26,782 | -23,373 | -26,304 | -28,714 | -30,026 | -28,613 |
キャッシュフロー計算書
（単位：百万円）
2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | |
|---|---|---|---|---|---|---|---|---|---|---|
営業CF | 14,737 | 27,067 | 15,327 | 21,703 | 21,129 | 27,468 | 14,380 | 13,336 | 9,253 | 2,577 |
投資CF | 473 | -4,105 | -3,503 | -3,245 | -5,744 | -2,528 | -1,644 | -7,888 | -2,627 | -5,854 |
財務CF | -7,900 | -5,984 | -9,800 | -9,530 | -9,524 | -10,173 | -8,752 | -8,129 | -6,990 | -5,658 |
フリーCF | 15,210 | 22,962 | 11,824 | 18,458 | 15,385 | 24,940 | 12,736 | 5,448 | 6,626 | -3,277 |